UnitedHealth Group Posts Q2 Revenue Gain
UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its earnings disappointment: adjusted earnings per share (non-GAAP) came in at $4.08, well below the $4.48 analyst consensus, while revenue (GAAP) was $111.6 billion -- slightly above the $111.5 billion projection.
Even with robust revenue growth, UnitedHealth Group's profitability was weighed down by higher medical costs and a steep drop in operating margins, driven in part by unusually high utilization in its Medicare business earlier in the year and industrywide regulatory headwinds. Overall, the period highlighted strong top-line momentum alongside both operational and margin pressures, with management citing a path to stabilization and renewed growth in 2026.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Source Fool.com
UnitedHealth Group Inc. Aktie
Klarer Community-Favorit: UnitedHealth Group Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Community-Kursziel von 331 € für UnitedHealth Group Inc. deutet auf eine deutliche Steigerung um mehr als 20% gegenüber dem aktuellen Kurs von 258.6 € hin.
